中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2012年
7期
966-967
,共2页
Graves眼病%糖皮质激素类%环磷酰胺
Graves眼病%糖皮質激素類%環燐酰胺
Graves안병%당피질격소류%배린선알
Graves ophthalmopathy%Glucocorticoids%Cyclophosphamide
目的 研究糖皮质激素单药及联合环磷酰胺治疗甲状腺相关眼病的疗效.方法 回顾性分析应用单纯糖皮质激素(单药组,甲泼尼龙)的35例患者和糖皮质激素联合环磷酰胺(联合组,泼尼松+环磷酰胺)治疗的16例患者的临床资料.结果 联合组总有效率(93.8%)显著高于单药组(68.6%)(x2=3.87,P<0.05).单纯应用糖皮质激素对CAS评分、突眼度、软组织炎症评分均有显著治疗效果,但疗效显著低于联合组(P<0.05).两组不良反应发生率差异无统计学意义.结论 联合糖皮质激素和环磷酰胺较单纯应用糖皮质激素,对甲状腺相关眼病的疗效更好,不良反应更低,尤其适合对激素治疗无效或效果不佳的患者.
目的 研究糖皮質激素單藥及聯閤環燐酰胺治療甲狀腺相關眼病的療效.方法 迴顧性分析應用單純糖皮質激素(單藥組,甲潑尼龍)的35例患者和糖皮質激素聯閤環燐酰胺(聯閤組,潑尼鬆+環燐酰胺)治療的16例患者的臨床資料.結果 聯閤組總有效率(93.8%)顯著高于單藥組(68.6%)(x2=3.87,P<0.05).單純應用糖皮質激素對CAS評分、突眼度、軟組織炎癥評分均有顯著治療效果,但療效顯著低于聯閤組(P<0.05).兩組不良反應髮生率差異無統計學意義.結論 聯閤糖皮質激素和環燐酰胺較單純應用糖皮質激素,對甲狀腺相關眼病的療效更好,不良反應更低,尤其適閤對激素治療無效或效果不佳的患者.
목적 연구당피질격소단약급연합배린선알치료갑상선상관안병적료효.방법 회고성분석응용단순당피질격소(단약조,갑발니룡)적35례환자화당피질격소연합배린선알(연합조,발니송+배린선알)치료적16례환자적림상자료.결과 연합조총유효솔(93.8%)현저고우단약조(68.6%)(x2=3.87,P<0.05).단순응용당피질격소대CAS평분、돌안도、연조직염증평분균유현저치료효과,단료효현저저우연합조(P<0.05).량조불량반응발생솔차이무통계학의의.결론 연합당피질격소화배린선알교단순응용당피질격소,대갑상선상관안병적료효경호,불량반응경저,우기괄합대격소치료무효혹효과불가적환자.
Objective To explore the effect of single glucocorticoid treatment and glucocorticoid joint cyclophosphamide treatment on thyroid-associated ophthalmopathy.Methods Retrospective analysis of clinical data of 35patients used single glucocorticoid( single medicine group) and 16 patients used glucocorticoids joint cyclophosphamide(joint group) was carried out.Results The effective rate of joint group(93.8% ) was significantly higher than single drug group (68.6%) ( x2 =3.87,P < 0.05).Simple using glucocorticoid had significant treatment effect at CAS score,prominent eyes degrees,soft tissue inflammation score,but the curative effect was significantly lower than the joint group ( P < 0.05 ).The adverse reaction rate had no significant difference between two groups.Conclusion Compared to single glucocorticoid treatment,the glucocorticoid joint cyclophosphamide treatment had better effect and lower adverse reaction rate,especially suitable for patients who had no effect or low effect on hormone therapy.